BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 10598726)

  • 1. Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial.
    Jaski BE; Lingle RJ; Kim J; Branch KR; Goldsmith R; Johnson MR; Lahpor JR; Icenogle TB; Piña I; Adamson R; Favrot LK; Dembitsky WP
    J Heart Lung Transplant; 1999 Nov; 18(11):1031-40. PubMed ID: 10598726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantation: an outlook for permanent assisting?
    de Jonge N; Kirkels H; Lahpor JR; Klöpping C; Hulzebos EJ; de la Rivière AB; Robles de Medina EO
    J Am Coll Cardiol; 2001 Jun; 37(7):1794-9. PubMed ID: 11401113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Ventricular Assist Device as a Bridge to Recovery for Patients With Advanced Heart Failure.
    Jakovljevic DG; Yacoub MH; Schueler S; MacGowan GA; Velicki L; Seferovic PM; Hothi S; Tzeng BH; Brodie DA; Birks E; Tan LB
    J Am Coll Cardiol; 2017 Apr; 69(15):1924-1933. PubMed ID: 28408022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in cardiopulmonary exercise testing parameters following continuous flow left ventricular assist device implantation and heart transplantation.
    Dunlay SM; Allison TG; Pereira NL
    J Card Fail; 2014 Aug; 20(8):548-54. PubMed ID: 24893345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.
    Ammirati E; Oliva FG; Colombo T; Russo CF; Cipriani MG; Garascia A; Guida V; Colombo G; Verde A; Perna E; Cannata A; Paino R; Martinelli L; Frigerio M
    Heart Vessels; 2016 May; 31(5):722-33. PubMed ID: 25735775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of exercise performance in patients with chronic severe heart failure versus left ventricular assist devices.
    Mancini D; Goldsmith R; Levin H; Beniaminovitz A; Rose E; Catanese K; Flannery M; Oz M
    Circulation; 1998 Sep; 98(12):1178-83. PubMed ID: 9743508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation.
    Coromilas E; Que-Xu EC; Moore D; Kato TS; Wu C; Ji R; Givens R; Jorde UP; Takayama H; Naka Y; George I; Mancini D; Schulze PC
    BMC Cardiovasc Disord; 2016 Jun; 16():138. PubMed ID: 27301475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which advanced heart failure therapy strategy is optimal for patients over 60 years old?
    Gernhofer YK; Braun OO; Brambatti M; Bui QM; Silva Enciso J; Greenberg BH; Adler E; Pretorius V
    J Cardiovasc Surg (Torino); 2019 Apr; 60(2):251-258. PubMed ID: 30168306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term heart transplant outcomes after lowering fixed pulmonary hypertension using left ventricular assist devices.
    Moayedifar R; Zuckermann A; Aliabadi-Zuckermann A; Riebandt J; Angleitner P; Dimitrov K; Schloeglhofer T; Rajek A; Laufer G; Zimpfer D
    Eur J Cardiothorac Surg; 2018 Dec; 54(6):1116-1121. PubMed ID: 29905775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of exercise during long-term support with a left ventricular assist device. Results of the experience with left ventricular assist device with exercise (EVADE) pilot trial.
    Jaski BE; Kim J; Maly RS; Branch KR; Adamson R; Favrot LK; Smith SC; Dembitsky WP
    Circulation; 1997 May; 95(10):2401-6. PubMed ID: 9170403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise performance of chronic heart failure patients in the early period of support by an axial-flow left ventricular assist device as destination therapy.
    Compostella L; Russo N; Setzu T; Compostella C; Bellotto F
    Artif Organs; 2014 May; 38(5):366-73. PubMed ID: 24117945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of new-generation intrapericardial continuous flow left ventricular assist devices as a bridge-to-transplant.
    Carrozzini M; Bejko J; Gambino A; Tarzia V; Lanera C; Gregori D; Gerosa G; Bottio T
    J Cardiovasc Med (Hagerstown); 2018 Dec; 19(12):739-747. PubMed ID: 30300244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily life activity in patients with left ventricular assist devices.
    Granegger M; Schlöglhofer T; Ober H; Zimpfer D; Schima H; Moscato F
    Int J Artif Organs; 2016 Jan; 39(1):22-7. PubMed ID: 26916759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist.
    Mishra V; Fiane AE; Winsnes BA; Geiran O; Sørensen G; Hagen TP; Gude E
    Scand Cardiovasc J; 2017 Feb; 51(1):1-7. PubMed ID: 27248460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise hemodynamics during long-term implantation of a left ventricular assist device in patients awaiting heart transplantation.
    Jaski BE; Branch KR; Adamson R; Peterson KL; Gordon JB; Hoagland PM; Smith SC; Daily PO; Dembitsky WP
    J Am Coll Cardiol; 1993 Nov; 22(6):1574-80. PubMed ID: 8227823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of peak exercise oxygen consumption combined with B-type natriuretic peptide levels for optimal timing of cardiac transplantation.
    Kato TS; Collado E; Khawaja T; Kawano Y; Kim M; Farr M; Mancini DM; Schulze PC
    Circ Heart Fail; 2013 Jan; 6(1):6-14. PubMed ID: 23204059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.
    Maybaum S; Mancini D; Xydas S; Starling RC; Aaronson K; Pagani FD; Miller LW; Margulies K; McRee S; Frazier OH; Torre-Amione G;
    Circulation; 2007 May; 115(19):2497-505. PubMed ID: 17485581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular assist device as bridge to heart transplantation--lessons learned with the MicroMed DeBakey axial blood flow pump.
    Salzberg S; Lachat M; Zünd G; Oechslin E; Schmid ER; DeBakey M; Turina M
    Eur J Cardiothorac Surg; 2003 Jul; 24(1):113-8. PubMed ID: 12853054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.